Advertisement

Psychiatry Weekly 5(25). Oct 25, 2010

Previous Issue     Archives: -Select Year- 2010 2009 2008 2007 2006 Next Issue

 

• Potential Implications of New Recommendations on Limiting Resident Duty Hours
• Orally Disintegrating Tablet Formulation of Olanzapine Has Similar Metabolic Effect to Standard Formulation
• Sound Sleep
• Autism and White Matter: New Sibling Comparison Findings
• Verbal and Cognitive Deficits Associated with Occasional Stimulant Use
• Do Training Levels Affect Efficacy of ERP for OCD?
• Brain Imaging Research and Psychiatry: Areas of Interest
• What is Valid Remission in First-Episode Psychosis?
• Managing Depression in Older Adults: Practical Approaches to Complex Patients
• FDA Approves Botox for Prophylactic Treatment of Chronic Migraine in Adults
• FDA Approves Lurasidone for the Treatment of Schizophrenia

 

The Glutamate System: A Breakdown of the Neurobiology, and Current Therapeutic Research Exposure and Response Therapy Designed for Pediatric OCD Mental Health Literacy and Depression Outcomes

Proposed Revisions of Dementia Diagnostic Categories for DSM-5 How Might A Smoke-Free Policy Affect A Large Psychiatric Hospital?

The Treatment Challenges of Adult Patients with ADHD Stressful Life Events and Depression Risks: A Twin Study Sleeping Pills and Anxiolytics Associated with Greater Mortality Risks Is Poor Social Cognition Linked to Prodromal Schizophrenia?